Salmonella Infections is an indication for drug development with over 30 pipeline drugs currently active. According to GlobalData, preregistered drugs for Salmonella Infections have a 100% likelihood of approval (LoA) indication benchmark. GlobalData’s report assesses how phase transition success rate (PTSR) and likelihood of approval (LoA) scores for pipeline drugs in Salmonella Infections compared to historical benchmarks. Buy the report here.
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.
Salmonella Infections overview
Salmonellosis is a symptomatic infection caused by bacteria of the Salmonella type. It is the most common disease to be known as food poisoning. The most common symptoms are diarrhea, fever, abdominal cramps, and vomiting. Signs and symptoms include enteriris, typhoid fever. It is caused by contaminated food, often having no unusual look or smell. Appropriate antibiotics, such as ceftriaxone, may be given to kill the bacteria, but are not necessary in most cases
See Also:
For a complete picture of PTSR and LoA scores for drugs in Salmonella Infections, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.